A pilot study assessing patterns of response or resistance to preoperative dose dense docetaxel in women with newly diagnosed breast cancer.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 23 May 2018
At a glance
- Drugs Docetaxel (Primary) ; Pegfilgrastim
- Indications Breast cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 28 Aug 2017 Planned End Date changed from 1 Jun 2016 to 1 Jun 2018.
- 04 Nov 2016 Planned End Date changed from 1 Jul 2016 to 1 Jun 2016.